China Resources Medical Holdings Company Limited

DB:1PH Voorraadrapport

Marktkapitalisatie: €654.1m

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

China Resources Medical Holdings Toekomstige groei

Future criteriumcontroles 3/6

China Resources Medical Holdings is forecast to grow earnings and revenue by 31.9% and 4.7% per annum respectively. EPS is expected to grow by 35.2% per annum. Return on equity is forecast to be 12% in 3 years.

Belangrijke informatie

31.9%

Groei van de winst

35.2%

Groei van de winst per aandeel

Healthcare winstgroei20.6%
Inkomstengroei4.7%
Toekomstig rendement op eigen vermogen12.0%
Dekking van analisten

Low

Laatst bijgewerkt28 Aug 2024

Recente toekomstige groei-updates

Recent updates

Winst- en omzetgroeiprognoses

DB:1PH - Toekomstschattingen van analisten en financiële gegevens uit het verleden (CNY Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/202611,206886N/A1,3873
12/31/202510,8737921,2131,5115
12/31/202410,4017119841,2355
6/30/20249,9702946211,162N/A
3/31/202410,0392766651,179N/A
12/31/202310,1082587081,195N/A
9/30/20239,9583387321,251N/A
6/30/20239,8094197561,307N/A
3/31/20238,8553425771,086N/A
12/31/20227,901266397864N/A
9/30/20226,891365422772N/A
6/30/20225,881463447680N/A
3/31/20225,164441479695N/A
12/31/20214,447418512710N/A
9/30/20214,031410392628N/A
6/30/20213,615402271546N/A
3/31/20213,183356349595N/A
12/31/20202,751310426644N/A
9/30/20202,404313483614N/A
6/30/20202,058315540584N/A
3/31/20202,087353435475N/A
12/31/20192,115391330366N/A
9/30/20192,112401263300N/A
6/30/20192,108412196234N/A
3/31/20192,084421236284N/A
12/31/20182,059431277334N/A
9/30/20181,996364317371N/A
6/30/20181,932298357407N/A
3/31/20181,905360N/A433N/A
12/31/20171,878421N/A460N/A
9/30/20171,784-446N/A377N/A
6/30/20171,690-1,312N/A294N/A
3/31/20171,611-1,410N/A259N/A
12/31/20161,533-1,507N/A224N/A
9/30/20161,504-656N/A227N/A
6/30/20161,475196N/A230N/A
3/31/20161,424181N/A231N/A
12/31/20151,372167N/A232N/A
9/30/20151,337208N/A246N/A
6/30/20151,302249N/A261N/A
3/31/20151,254240N/A268N/A
12/31/20141,206230N/A274N/A
9/30/20141,090176N/A238N/A
6/30/2014975122N/A202N/A
3/31/2014931106N/A186N/A
12/31/201388790N/A170N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: 1PH's forecast earnings growth (31.9% per year) is above the savings rate (0.8%).

Winst versus markt: 1PH's earnings (31.9% per year) are forecast to grow faster than the German market (20% per year).

Hoge groeiwinsten: 1PH's earnings are expected to grow significantly over the next 3 years.

Omzet versus markt: 1PH's revenue (4.7% per year) is forecast to grow slower than the German market (5.4% per year).

Hoge groei-inkomsten: 1PH's revenue (4.7% per year) is forecast to grow slower than 20% per year.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: 1PH's Return on Equity is forecast to be low in 3 years time (12%).

Ontdek groeibedrijven

7D

1Y

7D

1Y

7D

1Y